COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 40 years or older
- People who currently smoke or used to smoke, with a history of at least 10 pack-years of cigarette smoking (this is a measure of how much a person has smoked over time — confirm with trial site if unsure how this applies)
- People who have been diagnosed with COPD by a doctor, confirmed by a breathing test showing a specific result (FEV1/FVC less than 0.7), ranging from mild to very severe COPD
- People with a chronic bronchitis pattern, meaning they have regular sputum (mucus/phlegm) production or a productive cough more than 2 days per week for the past 3 months, lasting at least 2 years in a row — or a cough with phlegm almost every day or several times per week
- People who are able to complete all breathing tests during the study without needing extra oxygen
- People who are able to give their informed consent to participate
Who may not be able to join:
- People who do not have a COPD diagnosis
- People whose main lung condition is bronchiectasis, cystic fibrosis, or another long-term or acute lung disease involving infection or suppuration
- People who have had a COPD flare-up diagnosed by a doctor, or been hospitalised for lung-related symptoms, in the 4 weeks before the study's baseline testing
- People who currently use, or have used in the past 4 weeks, an oscillating positive expiratory pressure (OPEP) device — a type of airway clearance tool (confirm with trial site if unsure)
- People who are currently taking part in, or have taken part in, a standard Pulmonary Rehabilitation program in the 4 weeks before baseline testing, or who plan to do so during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bryan A. Ross, MD, MSc (Physiol), MSc (Epi), RI-MUHC/MUHC
Phone: (514) 843-1465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cough Impact Domain of the CASA-Q (co-primary outcome); Reactance at 5 Hertz (Hz) (co-primary outcome)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.